Literature DB >> 8248971

Cerebral venous thrombosis associated with pregnancy and puerperium. Review of 67 cases.

C Cantú1, F Barinagarrementeria.   

Abstract

BACKGROUND AND
PURPOSE: Cerebral venous thrombosis is characterized by its clinical pleomorphism and pathogenetic variability. We studied 67 patients with cerebral venous thrombosis associated with pregnancy and puerperium and compared them with 46 other cases unrelated to obstetric causes to disclose differences in their clinical presentation, neuroradiological findings, clinical course, and prognosis.
METHODS: In this retrospective study, we analyzed the clinical, laboratory, and neuroimaging findings of 113 patients collected consecutively at our institute. The diagnosis of cerebral venous thrombosis was confirmed by angiography, magnetic resonance imaging, or neuropathological study.
RESULTS: Patients with cerebral venous thrombosis associated with pregnancy and puerperium were younger (average age, 26 versus 36 years), and in most, the onset of symptoms was acute (82% versus 54%; P = .003). The evolution of symptoms reached a plateau within 10 days in 70% of patients with thrombosis from obstetric causes, compared with only 45% in those from other causes (P = .01). Anemia was more frequent in the obstetric group (64% versus 26%; P = .00001). There were no differences regarding neurological and neuroradiological findings. Although the initial severity of illness was similar in both groups, the final outcome was considered good in 80% of patients with obstetric causes, compared with 58% of patients with other causes (P = .01); mortality rates were 9% and 33%, respectively (P = .002).
CONCLUSIONS: Cerebral venous thrombosis associated with pregnancy and puerperium has a more acute onset and a better prognosis than thrombosis due to other causes. These findings might be helpful in the diagnostic and therapeutic strategies for patients with cerebral venous thrombosis.

Entities:  

Mesh:

Year:  1993        PMID: 8248971     DOI: 10.1161/01.str.24.12.1880

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  50 in total

1.  Risk of acute cerebrovascular events related to low oestrogen oral contraceptive treatment.

Authors:  U Scoditti; G P Buccino; M Pini; C Pattacini; D Mancia
Journal:  Ital J Neurol Sci       Date:  1998-02

Review 2.  Cerebral venous sinus thrombosis.

Authors:  Shelley Renowden
Journal:  Eur Radiol       Date:  2003-10-03       Impact factor: 5.315

Review 3.  Pseudotumor cerebri.

Authors:  Pietro Spennato; Claudio Ruggiero; Raffaele Stefano Parlato; Maria Consiglio Buonocore; Antonio Varone; Emilio Cianciulli; Giuseppe Cinalli
Journal:  Childs Nerv Syst       Date:  2010-08-19       Impact factor: 1.475

4.  Acute neurological issues in pregnancy and the peripartum.

Authors:  Catherine M Hosley; Louise D McCullough
Journal:  Neurohospitalist       Date:  2011-04

5.  Cerebral venous sinus thrombosis presenting in pregnancy and puerperium.

Authors:  Ganesh Dangal; Lok Bahadur Thapa
Journal:  BMJ Case Rep       Date:  2009-09-01

Review 6.  Cerebral venous thrombosis.

Authors:  P J Martin; T P Enevoldson
Journal:  Postgrad Med J       Date:  1996-02       Impact factor: 2.401

Review 7.  Intracranial haemorrhage in pregnancy.

Authors:  Jacob M Fairhall; Marcus A Stoodley
Journal:  Obstet Med       Date:  2009-11-30

Review 8.  The adaptation of the cerebral circulation to pregnancy: mechanisms and consequences.

Authors:  Marilyn J Cipolla
Journal:  J Cereb Blood Flow Metab       Date:  2013-01-16       Impact factor: 6.200

9.  Solitaire FR device for treatment of dural sinus thrombosis.

Authors:  Bryan Anthony Pukenas; Monisha Kumar; Michael Stiefel; Michelle Smith; Robert Hurst
Journal:  BMJ Case Rep       Date:  2012-12-19

10.  Should Magnetic Resonance Venography be Performed Routinely in all Patients Undergoing Evaluation for Idiopathic Intracranial Hypertension?

Authors:  Marc Dinkin; Heather E Moss
Journal:  J Neuroophthalmol       Date:  2015-12       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.